1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Diabetes

Type 2 diabetes: insulin degludec

Evidence summary [ESNM25] Published: 10 September 2013

  • Overview
  • Key points from the evidence
  • Relevance to NICE guidance programmes
  • Introduction
  • Product overview
  • Evidence review
  • Context
  • Estimated impact for the NHS
  • References
  • About this evidence summary
Download (PDF)

Advice

  • Next

This evidence summary updates and replaces NICE advice ESNM4


  • Next